Cargando…
Paclitaxel Delivery to the Brain for Glioblastoma Treatment
The development of paclitaxel-loaded polymeric nanoparticles for the treatment of brain tumors was investigated. Poly(lactide-glycolide) (PLGA) nanoparticles containing 10% w/w paclitaxel with a particle size of 216 nm were administered through intranasal and intravenous routes to male Sprague–Dawle...
Autores principales: | AbdEl-haq, Muhammad, Kumar, Awanish, Ait Mohand, Fatima-ezzahra, Kravchenko-Balasha, Nataly, Rottenberg, Yakir, Domb, Abraham J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380674/ https://www.ncbi.nlm.nih.gov/pubmed/37511480 http://dx.doi.org/10.3390/ijms241411722 |
Ejemplares similares
-
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
por: Rabah, Nadin, et al.
Publicado: (2023) -
Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
por: Cohen, Noam, et al.
Publicado: (2013) -
Anomalous Features of EMT during Keratinocyte Transformation
por: Geiger, Tamar, et al.
Publicado: (2008) -
Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
por: Jubran, Maria R., et al.
Publicado: (2020) -
Computational Surprisal Analysis Speeds-Up Genomic Characterization of Cancer Processes
por: Kravchenko-Balasha, Nataly, et al.
Publicado: (2014)